Insider · CIK 0001851964
Rocco Venezia
Files at ICPT (INTERCEPT PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Rocco Venezia files SEC Form 4 as officer at ICPT (INTERCEPT PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Rocco Venezia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | UTender of shares Common Stock | -10,782 | $19.00 | $205k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Common Stock | -14,669 | $19.00 | $279k | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -6,100 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -16,000 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,996 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -54 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -746 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -454 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -504 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -1,696 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -728 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -592 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -2,950 | - | - | 0 | Nov 13, 2023 |
| Nov 8, 2023 | ICPT INTERCEPT PHARMACEUTICALS, INC. | DDisposition to issuer Option to Purchase Common Stockderivative | -5,500 | - | - | 0 | Nov 13, 2023 |
Questions about Rocco Venezia
Answered from the filings on this page, as of the latest one.
Is Rocco Venezia buying or selling?
Rocco Venezia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Rocco Venezia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rocco Venezia has 0.
Where does Rocco Venezia file Form 4?
Rocco Venezia has filed Form 4 at ICPT (INTERCEPT PHARMACEUTICALS, INC.) as Chief Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.